Shanghai Unveils 17 Measures to Enhance Medical Administration Business Environment
Shanghai’s Medical Product Administration has unveiled a comprehensive set of 17 measures aimed at fostering...
Policy / Regulatory
NMPA Releases 78th Batch of Reference Drugs for Generic Quality Consistency Evaluation
The National Medical Products Administration (NMPA) has released the 78th batch of reference drugs for...
China’s NHC Outlines Cross-departmental Law Enforcement to Strengthen Medical Supervision
The National Health Commission (NHC) has issued a set of “Opinions on Strengthening Cross-departmental Law...
China Cracks Down on Medical Insurance Fraud with New Guidelines and Increased Prosecutions
China’s Supreme People’s Court, along with the Supreme People’s Procuratorate and the Ministry of Public...
US Senate Committee Backs Bill to Restrict Chinese Biotechnology Firms’ Access to American Genetic Data
The U.S. Senate’s homeland security committee has voted 11-1 in favor of the Prohibiting Foreign...
China’s Government Work Report Highlights Biomedicine Innovation and Healthcare Reforms
Chinese Premier Li Qiang presented a concise Government Work Report at the Second Session of...
China Aims to Insure 80% of Newborns with Basic Medical Insurance by 2024
The National Healthcare Security Administration (NHSA) and the National Health Commission (NHC), along with three...
Biden’s Executive Order May Restrict Data Access for China-Based Life Science Firms in the US
US President Joe Biden last week issued an Executive Order titled “Preventing Access to Americans’...
Hebei Province Proposes Measures for ‘Internet+’ Medical Services and Insurance Management
The Hebei provincial Healthcare Security Administration (HSA) bureau has released a draft set of Measures...
CDE Streamlines Patent Dispute Resolution for Generic Drug Filings with New Online Submission Process
The Center for Drug Evaluation (CDE) has announced a new initiative aimed at enhancing the...
China’s NMPA Updates Rules for Administrative Penalty Discretions in Drug Supervision
The National Medical Products Administration (NMPA) has issued the “Rules for the Application of Administrative...
Guangdong Province Releases New Batch of Urgently Needed Drugs and Medical Devices for Greater Bay Area
The Medical Products Administration and Health Commission of Guangdong province have released the sixth batch...
Fujian Province Issues Provisional Regulations for Managing Medical Representative Visits
The Fujian provincial health commission and medical products administration have jointly issued the “Provisional Regulations...
CDE Opens Consultation on 79th Batch of Generic Drug Reference Preparations
The Center for Drug Evaluation (CDE) has issued a call for feedback on the 79th...
FDA Issues Warning Letter to Sichuan Deebio for cGMP Violations in API Manufacturing
The U.S. Food and Drug Administration (FDA) has issued a warning letter to Sichuan Deebio...
Beijing, Tianjin, and Hebei Release Draft Proposal for Updated Drug Clinical Trial Inspection Standards
The medical products administration bureaus of Beijing, Tianjin, and Hebei province have released a draft...
China’s CDE Issues Guiding Principles for ADC Research and Evaluation
China’s Center for Drug Evaluation (CDE) has issued a notification outlining the “Guiding Principles for...
GSK and Peers Respond to FTC Criticism, Withdraw Patent Listings from US Orange Book
Three pharmaceutical companies, including the UK’s GSK (NYSE: GSK), have responded to the Federal Trade...
China’s NMPA Releases 77th Batch of Reference Drugs for Generic Quality Evaluation
The National Medical Products Administration (NMPA) has released the 77th batch of reference drugs for...
GSK’s Avodart Receives NMPA Approval to Resume Sales in China from September
The National Medical Products Administration (NMPA) has released a notification announcing that GlaxoSmithKline’s (GSK) Avodart...